Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (145) 145
Publication (9) 9
Newspaper Article (6) 6
Book / eBook (4) 4
Conference Proceeding (3) 3
Book Review (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (50) 50
humans (47) 47
male (47) 47
aged (31) 31
middle aged (31) 31
prostate cancer (31) 31
prostatic neoplasms - pathology (22) 22
cancer (21) 21
radical prostatectomy (21) 21
prostatic neoplasms - surgery (20) 20
urology & nephrology (19) 19
risk factors (16) 16
prostate-specific antigen - blood (15) 15
risk (14) 14
analysis (13) 13
prostatectomy - methods (13) 13
prostatic neoplasms - mortality (13) 13
men (12) 12
neoplasm grading (12) 12
prospective studies (12) 12
research (12) 12
follow-up studies (11) 11
oncology (11) 11
prostatic neoplasms - blood (11) 11
survival (11) 11
treatment outcome (11) 11
mortality (10) 10
neoplasm staging (10) 10
genotype (9) 9
polymorphism, single nucleotide (9) 9
specimens (9) 9
adult (8) 8
animals (8) 8
biochemical recurrence (8) 8
carcinoma (8) 8
disease-free survival (8) 8
metaanalysis (8) 8
outcomes (8) 8
surgery (8) 8
care and treatment (7) 7
denmark (7) 7
epidemiology (7) 7
fysik (7) 7
genetic aspects (7) 7
genome-wide association study (7) 7
genomes (7) 7
impact (7) 7
multivariate analysis (7) 7
physical sciences (7) 7
plant science (7) 7
progression (7) 7
prostate (7) 7
prostatectomy (7) 7
quantitative trait loci (7) 7
risk assessment (7) 7
science (7) 7
wheat (7) 7
alleles (6) 6
biochemistry & molecular biology (6) 6
chromosome mapping (6) 6
denmark - epidemiology (6) 6
food and beverages (6) 6
health aspects (6) 6
medicine (6) 6
medicine, general & internal (6) 6
multidisciplinary sciences (6) 6
prediction (6) 6
prognosis (6) 6
prostatic neoplasms - diagnosis (6) 6
prostatic neoplasms - therapy (6) 6
studies (6) 6
subatomic physics (6) 6
subatomär fysik (6) 6
survival rate (6) 6
time factors (6) 6
aged, 80 and over (5) 5
androgen antagonists - therapeutic use (5) 5
biology (5) 5
chemistry (5) 5
cohort studies (5) 5
female (5) 5
follow-up (5) 5
genetics (5) 5
kaplan-meier estimate (5) 5
management (5) 5
phenotype (5) 5
positive surgical margins (5) 5
prostatic neoplasms - epidemiology (5) 5
prostatic neoplasms - genetics (5) 5
public health (5) 5
radiotherapy (5) 5
research article (5) 5
retrospective studies (5) 5
survival analysis (5) 5
usage (5) 5
biopsy (4) 4
calcium-binding proteins - metabolism (4) 4
case-control studies (4) 4
chemistry, multidisciplinary (4) 4
chemistry, physical (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Diagnostic characteristics of lethal prostate cancer
by John Thomas Helgstrand and Martin Andreas Røder and Nina Klemann and Birgitte Grønkær Toft and Klaus Brasso and Ben Vainer and Peter Iversen
European Journal of Cancer, ISSN 0959-8049, 10/2017, Volume 84, p. 18
Background: The diagnostic characteristics of men who eventually die from prostate cancer (PCa) and the extent to which early diagnostic strategies have... 
Prostate-specific antigen | Population studies | Epidemiology | Survival | Risk factors | Lymph nodes | Metastases | Lead time | Medical prognosis | Men | Fatalities | Diagnostic systems | Trends | Diagnosis | Prostate cancer | Prostate | Cancer
Journal Article
Details down arrow
2. Prostate cancer surgery
by Røder, Martin Andreas and Iversen, Peter
Ugeskrift for laeger, 11/2018, Volume 180, Issue 46
Radical prostatectomy (RP) remains the preferred treatment option for men with localised prostate cancer (PCa). Following the introduction in 1995,... 
Journal Article
Details down arrow
3. Prostate cancer surgery
by Røder, Martin Andreas and Iversen, Peter
Ugeskrift for laeger, 11/2018, Volume 180, Issue 46
Journal Article
Details down arrow
4. Radical prostatectomy for clinically localised prostate cancer at rigshospitalet 1995-2011
by Røder, Martin Andreas
Danish Medical Journal, ISSN 2245-1919, 12/2013, Volume 60, Issue 12
MALE PELVIS | MEDICINE, GENERAL & INTERNAL | IMPACT | BIOCHEMICAL RECURRENCE | POSTOPERATIVE RADIOTHERAPY | POSITIVE SURGICAL MARGINS | FOLLOW-UP | RISK | RETROPUBIC PROSTATECTOMY | RANDOMIZED CONTROLLED-TRIAL | ADJUVANT RADIOTHERAPY
Journal Article
Details down arrow
5. Full Text Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer
: Utility of PSA doubling time in patients on active surveillance
by Thomsen, Frederik Birkebaek and Christensen, Ib Jarle and Brasso, Klaus and Røder, Martin Andreas and Iversen, Peter
BJU International, ISSN 1464-4096, 05/2014, Volume 113, Issue 5b, pp. E98 - E105
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Radikal prostatektomi ved avanceret prostatacancer
by Røder, Martin Andreas and Iversen, Peter
Ugeskrift for Laeger, ISSN 0041-5782, 12/2012, Volume 174, Issue 50, pp. 3160 - 3161
Journal Article
Details down arrow
7. Full Text Risk of biochemical recurrence and positive surgical margins in patients with pT2 prostate cancer undergoing radical prostatectomy
: Impact of Nerve-Sparing Surgery
by Røder, Martin Andreas and Thomsen, Frederik Birkebaek and Berg, Kasper Drimer and Christensen, Ib Jarle and Brasso, Klaus and Vainer, Ben and Iversen, Peter
Journal of Surgical Oncology, ISSN 0022-4790, 02/2014, Volume 109, Issue 2, pp. 132 - 138
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
by Schumacher, Fredrick R and Al Olama, Ali Amin and Berndt, Sonja I and Benlloch, Sara and Ahmed, Mahbubl and Saunders, Edward J and Dadaev, Tokhir and Leongamornlert, Daniel and Anokian, Ezequiel and Cieza-Borrella, Clara and Goh, Chee and Brook, Mark N and Sheng, Xin and Fachal, Laura and Dennis, Joe and Tyrer, Jonathan and Muir, Kenneth and Lophatananon, Artitaya and Stevens, Victoria L and Gapstur, Susan M and Carter, Brian D and Tangen, Catherine M and Goodman, Phyllis J and Thompson, Ian M and Batra, Jyotsna and Chambers, Suzanne and Moya, Leire and Clements, Judith and Horvath, Lisa and Tilley, Wayne and Risbridger, Gail P and Gronberg, Henrik and Aly, Markus and Nordström, Tobias and Pharoah, Paul and Pashayan, Nora and Schleutker, Johanna and Tammela, Teuvo L. J and Sipeky, Csilla and Auvinen, Anssi and Albanes, Demetrius and Weinstein, Stephanie and Wolk, Alicja and Håkansson, Niclas and West, Catharine M. L and Dunning, Alison M and Burnet, Neil and Mucci, Lorelei A and Giovannucci, Edward and Andriole, Gerald L and Cussenot, Olivier and Cancel-Tassin, Géraldine and Koutros, Stella and Beane Freeman, Laura E and Sorensen, Karina Dalsgaard and Orntoft, Torben Falck and Borre, Michael and Maehle, Lovise and Grindedal, Eli Marie and Neal, David E and Donovan, Jenny L and Hamdy, Freddie C and Martin, Richard M and Travis, Ruth C and Key, Tim J and Hamilton, Robert J and Fleshner, Neil E and Finelli, Antonio and Ingles, Sue Ann and Stern, Mariana C and Rosenstein, Barry S and Kerns, Sarah L and Ostrer, Harry and Lu, Yong-Jie and Zhang, Hong-Wei and Feng, Ninghan and Mao, Xueying and Guo, Xin and Wang, Guomin and Sun, Zan and Giles, Graham G and Southey, Melissa C and MacInnis, Robert J and Fitzgerald, Liesel M and Kibel, Adam S and Drake, Bettina F and Vega, Ana and Gómez-Caamaño, Antonio and Szulkin, Robert and Eklund, Martin and Kogevinas, Manolis and Llorca, Javier and Castaño-Vinyals, Gemma and Penney, Kathryn L and Stampfer, Meir and Park, Jong Y and Sellers, Thomas A and Lin, Hui-Yi and Stanford, Janet L and Cybulski, Cezary and ... and Profile Study and Canary PASS Investigators and Canc Prostate Sweden CAPS and IMPACT Study and Prostate Canc Genome-wide As and APCB and Breast Prostate Canc Cohort Consor and PRACTICAL Prostate Canc As and Genetic Assoc Mech Oncology GAME and Breast and Prostate Cancer Cohort Consortium (BPC3) and Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS) and Australian Prostate Cancer BioResource (APCB) and Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium and Cancer of the Prostate in Sweden (CAPS) and PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium and The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium and The IMPACT Study and The Profile Study and The Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Ortopedi and Uppsala universitet and Institutionen för kirurgiska vetenskaper
Nature Genetics, ISSN 1061-4036, 07/2018, Volume 50, Issue 7, pp. 928 - 936
Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified more than 100 prostate cancer (PrCa)-susceptibility loci. We... 
CONSORTIUM | METAANALYSIS | GENE | VARIANTS | PATHWAY | GENETICS & HEREDITY | RISK | MULTIPLE LOCI | IDENTIFICATION | GENOME-WIDE ASSOCIATION | PREDICTION | Genetic Predisposition to Disease | Prostatic Neoplasms - genetics | Humans | Genotype | Male | Risk | Polymorphism, Single Nucleotide | Genetic Loci | Genome-Wide Association Study - methods | Case-Control Studies | Case studies | Genome-wide association studies | Usage | Men | Genetic aspects | Health aspects | Prostate cancer | Risk factors | Genealogy | Data processing | Genomes | Mapping | Biology | Family medical history | Loci | Meta-analysis | Confidence intervals | Consortia | Signal transduction | Software | Gene mapping | Health risk assessment | Prostate | Genotypes | Cancer | Basic Medicine | Medical Genetics | Medicinsk genetik | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Temporal Trends in Clinical and Pathological Characteristics for Men Undergoing Radical Prostatectomy Between 1995 and 2013 at Rigshospitalet, Copenhagen, Denmark, and Stanford University Hospital, United States
by Loft, Mathias Dyrberg and Berg, Kasper Drimer and Kjaer, Andreas and Iversen, Peter and Ferrari, Michelle and Zhang, Chiyuan A and Brasso, Klaus and Brooks, James D and Røder, Martin Andreas
Clinical genitourinary cancer, 09/2017
To analyze how prostate-specific antigen (PSA) screening and practice patterns has affected trends in tumor characteristics in men undergoing radical... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Serum testosterone level as a predictor of biochemical failure after radical prostatectomy for localized prostate cancer
: TESTOSTERONE AS A PREDICTOR OF BF
by Røder, Martin Andreas and Christensen, Ib Jarle and Berg, Kasper D and Gruschy, Lisa and Brasso, Klaus and Iversen, Peter
BJU International, ISSN 1464-4096, 02/2012, Volume 109, Issue 4, pp. 520 - 524
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
by Al Olama, Ali Amin and Kote-Jarai, Zsofia and Berndt, Sonja I and Conti, David V and Schumacher, Fredrick and Han, Ying and Benlloch, Sara and Hazelett, Dennis J and Wang, Zhaoming and Saunders, E and Leongamornlert, Daniel and Lindstrom, Sara and Jugurnauth-Little, Sara and Dadaev, Tokhir and Tymrakiewicz, Malgorzata and Stram, Daniel O and Rand, Kristin and Wan, Peggy and Stram, Alex and Sheng, Xin and Pooler, Loreall C and Park, Karen and Xia, Lucy and Tyrer, Jonathan and Kolonel, Laurence N and Le Marchand, Loic and Hoover, Robert N and Machiela, Mitchell J and Yeager, Merideth and Burdette, Laurie and Chung, Charles C and Hutchinson, Amy and Yu, Kai and Goh, Chee and Ahmed, Mahbubl and Govindasami, Koveela and Guy, Michelle and Tammela, Teuvo L J and Auvinen, Anssi and Wahlfors, Tiina and Schleutker, Johanna and Visakorpi, Tapio and Leinonen, Katri A and Xu, Jianfeng and Aly, Markus and Donovan, Jenny and Travis, Ruth C and Key, Tim J and Siddiq, Afshan and Canzian, Federico and Khaw, Kay-Tee and Takahashi, Atsushi and Kubo, Michiaki and Pharoah, Paul and Pashayan, Nora and Weischer, Maren and Nordestgaard, Borge G and Nielsen, Sune F and Klarskov, Peter and Røder, Martin Andreas and Iversen, Peter and Thibodeau, Stephen N and McDonnell, Shannon K and Schaid, Daniel J and Stanford, Janet L and Kolb, Suzanne and Holt, Sarah and Knudsen, Beatrice and Coll, Antonio Hurtado and Gapstur, Susan M and Diver, W Ryan and Stevens, Victoria L and Maier, Christiane and Luedeke, Manuel and Herkommer, Kathleen and Rinckleb, Antje E and Strom, Sara S and Pettaway, Curtis and Yeboah, Edward D and Tettey, Yao and Biritwum, Richard B and Adjei, Andrew A and Tay, Evelyn and Truelove, Ann and Niwa, Shelley and Chokkalingam, Anand P and Cannon-Albright, Lisa and Cybulski, Cezary and Wokołorczyk, Dominika and Kluźniak, Wojciech and Park, Jong and Sellers, Thomas and Lin, Hui-Yi and Isaacs, William B and Partin, Alan W and Brenner, Hermann and Dieffenbach, Aida Karina and Stegmaier, Christa and Chen, Constance and Giovannucci, Edward L and ... and Practical Prostate Canc Associatio and GAME-ON ELLIPSE Consortium and Breast Prostate Canc Cohort Consor and COGS Consortium and Breast and Prostate Cancer Cohort Consortium (BPC3) and GAME-ON/ELLIPSE Consortium and COGS (Collaborative Oncological Gene-environment Study) Consortium and PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium and The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium and The Breast and Prostate Cancer Cohort Consortium (BPC3) and The COGS (Collaborative Oncological Gene-environment Study) Consortium and The GAME-ON/ELLIPSE Consortium
Nature Genetics, ISSN 1061-4036, 09/2014, Volume 46, Issue 10, pp. 1103 - 1109
Genome-wide association studies (GWAS) have identified 76 variants associated with prostate cancer risk predominantly in populations of European ancestry. To... 
COMMON VARIANTS | GLIOMA | MEN | GENETICS & HEREDITY | RISK | JAPANESE | MYOSIN VI | 22Q13 | GENOME-WIDE ASSOCIATION | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Prostatic Neoplasms - genetics | Risk Assessment | Humans | Risk Factors | Genetic Loci - genetics | Genotype | Male | Polymorphism, Single Nucleotide | Quantitative trait loci | Genetic aspects | Prostate cancer | Identification and classification | Health aspects | Risk factors | Studies | Genealogy | Men | Genomes | Health risk assessment | Meta-analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Radical prostatectomy for clinically localised prostate cancer at Rigshospitalet 1995-2011 - an analysis of surgical and oncological outcome
by Røder, Martin A.ndreas
Danish medical journal, 12/2013, Volume 60, Issue 12, p. B4752
RP for localized PCa was introduced at Rigshospitalet in 1995. Since then, the incidence of PCa and number of RPs performed every year has increased... 
Prostatic Neoplasms - pathology | Prostatectomy - methods | Prostatic Neoplasms - surgery | Humans | Risk Factors | Organ Sparing Treatments | Male | Treatment Outcome | Prostate-Specific Antigen - blood | Neoplasm, Residual | Disease-Free Survival | Hospitals | Denmark | Prostatic Neoplasms - blood
Journal Article
Details down arrow
13. Full Text Risk of depression following prostate cancer work-up: A nationwide study
by Friberg, Anne Sofie and Brasso, Klaus and Andersen, Elisabeth Wreford and Larsen, Signe Benzon and Helgstrand, John Thomas and Røder, Martin Andreas and Johansen, Christoffer and Dalton, Susanne Oksbjerg
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 5061 - 5061
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Radical prostatectomy in patients with advanced prostate cancer
by Røder, Martin Andreas and Iversen, Peter
Ugeskrift for laeger, 12/2012, Volume 174, Issue 50, p. 3160
There is no evidence for the use of radical prostatectomy in patients with disseminated prostate cancer. However, development of new and effective treatment... 
Prostatectomy - methods | Prostatic Neoplasms - surgery | Humans | Middle Aged | Male | Treatment Outcome | Combined Modality Therapy | Prostatic Neoplasms - diagnosis | Adenocarcinoma - drug therapy | Prostate-Specific Antigen - analysis | Prostatic Neoplasms - therapy | Adenocarcinoma - diagnosis | Neoplasm Grading | Adult | Adenocarcinoma - surgery
Journal Article
Details down arrow
15. Full Text Prostate needle biopsies: interobserver variation and clinical consequences of histopathological re-evaluation
: PROSTATE NEEDLE BIOPSIES
by BERG, KASPER DRIMER and TOFT, BIRGITTE GRØNKAER and RØDER, MARTIN ANDREAS and BRASSO, KLAUS and VAINER, BEN and IVERSEN, PETER
APMIS, ISSN 0903-4641, 04/2011, Volume 119, Issue 4-5, pp. 239 - 246
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Therapeutic vaccines is a novel approach in castration-resistant prostate cancer treatment
by Djurhuus, Sissal Sigmundsdòttir and Brasso, Klaus and Berg, Kasper Drimer and Iversen, Peter and Røder, Martin Andreas
Ugeskrift for laeger, 05/2015, Volume 177, Issue 20
Journal Article
Details down arrow
17. Therapeutic vaccines is a novel approach in castration-resistant prostate cancer treatment
by Djurhuus, Sissal Sigmundsdòttir and Brasso, Klaus and Berg, Kasper Drimer and Iversen, Peter and Røder, Martin Andreas
Ugeskrift for laeger, 05/2015, Volume 177, Issue 20
Castration-resistant prostate cancer (CRPC) is defined as tumour progression despite castrate levels of serum testosterone. During the past decade a number of... 
Immunotherapy - methods | Cancer Vaccines - pharmacology | Humans | Prostatic Neoplasms, Castration-Resistant - immunology | Tissue Extracts - adverse effects | Tissue Extracts - pharmacology | Cancer Vaccines - adverse effects | Male | Antineoplastic Agents - therapeutic use | Tissue Extracts - therapeutic use | Cancer Vaccines - therapeutic use | Antineoplastic Agents - adverse effects | Prostatic Neoplasms, Castration-Resistant - therapy | Antineoplastic Agents - pharmacology
Journal Article
Details down arrow
18. Full Text Nationwide analysis: Changes in the natural history of low risk localized prostate cancer
by John, Helgstrand Thomas and Klemann, Nina and Toft, Birgitte Grønkaer and Vainer, Ben and Røder, Martin Andreas and Iversen, Peter and Brasso, Klaus
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 2017, Issue 1_suppl, pp. 12 - 12
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Survival trends in patients diagnosed with metastatic prostate cancer: A nationwide analysis
by Thomas Helgstrand, John and Klemann, Nina and Toft, Birgitte Grønkaer and Vainer, Ben and Brasso, Klaus and Brooks, James D and Iversen, Peter and Røder, Martin Andreas
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 6_suppl, pp. 171 - 171
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Nationwide analysis: Changes in the natural history of low risk localized prostate cancer
by Thomas Helgstrand, John and Klemann, Nina and Toft, Birgitte Grønkaer and Vainer, Ben and Røder, Martin Andreas and Iversen, Peter and Brasso, Klaus
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 6_suppl, pp. 12 - 12
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.